Hims & Hers stock fell by 8% following the publication of an investigative report into its GLP-1 drug compounding service.
The report was compiled by Hunterbrook Media, a fairly unique firm that publishes investigative stories about companies that its affiliated hedge fund, Hunterbrook Capital, invests in or short sells.
Strategist | strategy-catalyst
Investigative report raises questions about Hims' GLP-1 compounding business

Related Topics:
Health Policy and Advocacy Relevant Roles:
Chief Strategy Officers